These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 316742)

  • 21. Effectiveness of vaccination against cholera and typhoid fever.
    Germanier R
    Monogr Allergy; 1975; 9():217-30. PubMed ID: 1090807
    [No Abstract]   [Full Text] [Related]  

  • 22. Recombinant attenuated Vibrio cholerae strains used as live oral vaccines.
    Kaper JB; Levine MM
    Res Microbiol; 1990; 141(7-8):901-6. PubMed ID: 2101480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction of an engineered bivalent vaccine strain consisting of Vibrio cholerae CT-B and LPS-O antigens.
    Yu X; Ma Q
    Chin J Biotechnol; 1994; 10(4):225-32. PubMed ID: 7780018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possibilities of immunization against cholera and related enterotoxic enteropathies.
    Finkelstein RA
    Dev Biol Stand; 1976; 33():102-7. PubMed ID: 955264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of cross-protection against diarrhea due to Vibrio cholerae O1 after oral immunization of rabbits with V. cholerae O139 Bengal.
    Albert MJ; Alam K; Rahman AS; Huda S; Sack RB
    J Infect Dis; 1994 Mar; 169(3):709-10. PubMed ID: 8158063
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunity in cholera.
    Ghosh AK
    Indian J Pathol Bacteriol; 1974 Apr; 17(2):118-25. PubMed ID: 4455619
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cholera update and vaccination problems].
    Fournier JM; Villeneuve S
    Med Trop (Mars); 1998; 58(2 Suppl):32-5. PubMed ID: 9812307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxin.
    Fontana MR; Monaci E; Yanqing L; Guoming Q; Duan G; Rappuoli R; Pizza M
    Vaccine; 2000 Aug; 19(1):75-85. PubMed ID: 10924789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reactogenicity and immunogenicity of oral cholera vaccine in Thai volunteers.
    Migasena S; Pitisuttitham P; Supanaranond W; Desakorn V; Prayurahong B; Suntharasamai P
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):423-8. PubMed ID: 3217824
    [No Abstract]   [Full Text] [Related]  

  • 30. Construction and evaluation of a O139 Vibrio cholerae vaccine candidate based on a hemA gene mutation.
    Ravichandran M; Ali SA; Rashid NH; Kurunathan S; Yean CY; Ting LC; Bakar AS; Lalitha P; Zainuddin ZF
    Vaccine; 2006 May; 24(18):3750-61. PubMed ID: 16102875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colonization & protection in infant rabbits by a choleragenoid producing strain of Vibrio cholerae.
    Sinha VB; Srivastava BS
    Indian J Med Res; 1986 Aug; 84():139-41. PubMed ID: 3759164
    [No Abstract]   [Full Text] [Related]  

  • 32. [The problem of oral immunization (author's transl)].
    Hof H; Finger H
    Immun Infekt; 1974 Feb; 2(1):63-8. PubMed ID: 4377567
    [No Abstract]   [Full Text] [Related]  

  • 33. [Travellers' compliance with the use of an oral cholera vaccine].
    Cucchi A; Cova M; Merciadri GV; Serenelli C; Ghiselli G; Buriani O; Gabutti G
    Ig Sanita Pubbl; 2010; 66(4):409-18. PubMed ID: 21132038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral vaccination against enteric bacterial infections: an overview.
    Germanier R
    Infection; 1985; 13 Suppl 2():S206-10. PubMed ID: 3902655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Determination of Vibrio antibody titers during anti-cholera vaccination].
    Dirimci OT; Cinar V
    Turk Hij Tecr Biyol Derg (1961); 1973; 33(2-3):118-28. PubMed ID: 4807572
    [No Abstract]   [Full Text] [Related]  

  • 36. Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine.
    Cash RA; Music SI; Libonati JP; Craig JP; Pierce NF; Hornick RB
    J Infect Dis; 1974 Oct; 130(4):325-33. PubMed ID: 4443613
    [No Abstract]   [Full Text] [Related]  

  • 37. Recombinant derivative of a naturally occurring non-toxinogenic Vibrio cholerae 01 expressing the B subunit of cholera toxin: a potential oral vaccine strain.
    Dasgupta U; Bhadra RK; Panda DK; Deb A; Das J
    Vaccine; 1994 Mar; 12(4):359-64. PubMed ID: 8178559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic significance of the nonlipopolysaccharide antigens of Vibrio cholerae.
    Attridge SR; Rowley D
    J Infect Dis; 1983 Nov; 148(5):931-9. PubMed ID: 6195273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High hopes for oral cholera vaccine.
    Bull World Health Organ; 2010 Mar; 88(3):165-6. PubMed ID: 20428379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of Vibrio cholerae outer membrane vesicles secreted at various environmental conditions.
    Adriani R; Mousavi Gargari SL; Nazarian S; Sarvary S; Noroozi N
    Vaccine; 2018 Jan; 36(2):322-330. PubMed ID: 29191736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.